Progenity (PROG) Completes Transfer of Liquid Biopsy Technologies May 5, 2022 06:30AM
Progenity Announces Successful Transfer of Liquid Biopsy Technologies May 5, 2022 06:30AM
Progenity Announces Successful Transfer of Liquid Biopsy Technologies May 5, 2022 06:30AM
Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc. May 3, 2022 09:00AM
Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc. May 3, 2022 09:00AM
View Older Stories

Apr 25, 2022 09:00AM Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms
Apr 25, 2022 09:00AM Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms
Apr 12, 2022 09:04AM Progenity (PROG) to Become Biora Therapeutics (BIOR) as it Completes Transformation
Apr 12, 2022 09:00AM Progenity to Become Biora Therapeutics as it Completes Transformation
Apr 12, 2022 09:00AM Progenity to Become Biora Therapeutics as it Completes Transformation
Apr 6, 2022 09:00AM Progenity Announces Two Poster Presentations at Controlled Release Society 2022
Apr 6, 2022 09:00AM Progenity Announces Two Poster Presentations at Controlled Release Society 2022
Mar 28, 2022 04:01PM Progenity (PROG) Reports Q4, Provides Corporate Update
Mar 28, 2022 04:01PM Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 28, 2022 04:01PM Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 16, 2022 04:23PM Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update
Mar 16, 2022 04:23PM Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update
Mar 10, 2022 09:02AM Progenity (PROG) Progresses its Drug Delivery System Clinical Device Performance Studies
Mar 10, 2022 09:00AM Progenity Progresses its Drug Delivery System Clinical Device Performance Studies
Mar 10, 2022 09:00AM Progenity Progresses its Drug Delivery System Clinical Device Performance Studies
Feb 28, 2022 09:00AM Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
Feb 28, 2022 09:00AM Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
Feb 22, 2022 09:00AM Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22
Feb 22, 2022 09:00AM Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22
Feb 16, 2022 09:00AM Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Feb 16, 2022 09:00AM Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Jan 25, 2022 04:09PM Progenity (PROG) Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent
Jan 25, 2022 04:05PM Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent
Jan 25, 2022 04:05PM Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent
Jan 11, 2022 06:30AM Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Jan 11, 2022 06:30AM Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Jan 5, 2022 06:30AM Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22
Jan 5, 2022 06:30AM Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22
Jan 3, 2022 06:30AM Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
Jan 3, 2022 06:30AM Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
Dec 20, 2021 04:05PM Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
Dec 20, 2021 04:05PM Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
Dec 2, 2021 06:30AM Progenity (PROG) Announces New Patent for Single-Molecule Detection Technology
Dec 2, 2021 06:30AM Progenity Announces New Patent for Single-Molecule Detection Technology
Dec 2, 2021 06:30AM Progenity Announces New Patent for Single-Molecule Detection Technology
Nov 23, 2021 06:30AM Progenity (PROG) Receives $44M in Warrant Proceeds, Strengthens its Liquidity Position
Nov 23, 2021 06:30AM Progenity Strengthens its Liquidity Position
Nov 23, 2021 06:30AM Progenity Strengthens its Liquidity Position
Nov 15, 2021 06:30AM Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Nov 15, 2021 06:30AM Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Nov 10, 2021 04:01PM Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Nov 10, 2021 04:01PM Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Nov 9, 2021 06:30AM Progenity (PROG) Appoints Adi Mohanty as CEO
Nov 9, 2021 06:30AM Progenity Appoints Adi Mohanty as Chief Executive Officer
Nov 9, 2021 06:30AM Progenity Appoints Adi Mohanty as Chief Executive Officer
Nov 4, 2021 06:33AM Progenity (PROG) Appoints Jill Howe to its Board
Nov 4, 2021 06:30AM Progenity Announces Appointment of Jill Howe to its Board of Directors
Nov 4, 2021 06:30AM Progenity Announces Appointment of Jill Howe to its Board of Directors
Nov 3, 2021 07:30AM Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update
Nov 3, 2021 07:30AM Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update
View Older Stories